Skip to content

Author

Dinda Herawati

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Cost-Effectiveness Analysis of the Use of the Antihypertensive Drugs Candesartan and Ramipril in Hospitalized Patients with Heart Failure and Hypertension

It can be concluded that, based on the results of the cost-effectiveness analysis, ramipril therapy is more cost-effective than candesartan from both perspectives.

Dinda Herawati, Niken Luthfiyanti, Bagas Ardiyantoro · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.